The MEA soft tissue repair market size is expected to grow at a CAGR of 6.013% between 2022 to 2027. It is estimated to be worth USD 1.16 billion in 2022 and USD 1.55 billion by 2027.
The rise in sports-related injuries is one of the significant factors promoting the MEA soft tissue repair market growth. According to the International Journal of Environmental Research and Public Health, 41% of those who participated in competitions were injured. The average number of injuries per 1000 hours was 3. Football had the highest percentage of sports-related injuries at 13%, followed by lumbar muscle sprains at 12%, ankle sprains at 14%, and bone fractures were the most common injuries at 10%. This has led to an increase in demand for soft tissue repair products. In addition, factors such as the increase in the geriatric population and the growth in the number of trauma cases are further estimated to accelerate the market's growth rate in this region. Other factors, such as increased awareness of orthopedic disorders and other related ailments, improved reimbursement policies, untapped emerging markets, and increased healthcare spending, are also expected to drive market growth. In addition, the launch of new products in emerging countries is expected to create lucrative opportunities in the market.
The increase in obesity and old age is driving the growth of the Middle East & Africa soft tissue repair market. Obesity is linked to soft tissue damage and osteoarthritis, requiring soft tissue repair procedures. According to the global disease burden, more than 4.6 million people died from being overweight or obese in 2017. According to the WHO, more than 2.1 billion adults over 18 were overweight in 2017. More than 690 million people are currently reported to be overweight worldwide. In 2020, 40 million children under five were overweight or obese. In addition, the increase in recreational centers, sports avenues, and gyms is also boosting the market's growth.
However, the high cost of surgical procedures, limited sports injuries-related knowledge, and the lack of reimbursement policies may hamper the growth of the MEA soft tissue repair market during the analysis period.
This research report on the Middle East and Africa soft tissue repair market has been segmented and sub-segmented into the following categories:
Saudi Arabia dominates the Middle East & African soft tissue repair market in terms of market share in 2020. It is estimated to continue to thrive during the forecast period. The market growth is due to rising healthcare spending and many soft tissue repair surgeries. The region is very well known for the high number of football-related injuries attributed to the game's popularity in the region. New product launches are expected to create lucrative opportunities in the market. The robust research and development (R&D) sector and the availability of research and innovation funding opportunities will support regional market growth. According to the World Health Organization, in 2018, regional health spending amounted to USD 83 billion, or about 10% of the total GDP.
The United Arab Emirates is expected to have phenomenal market growth during the forecast period due to the increasing demand for medical technologies, growing health awareness, a high rate of increase in population, and the growing prevalence of orthopedic diseases. According to the United Nations Economic and Social Commission, in 2017, around 12% of the region's population was 60 years or older, and expected to reach over 15% by 2045.
On the other hand, the African region is estimated to have the lowest share of the MEA soft tissue repair market due to the low economic development, especially in the sub-Saharan region. However, the local government is trying with the United Nations to elevate the poor healthcare infrastructure in rural and underdeveloped regions. Therefore, the market in this region is attracting interest from key market players for the distribution of soft tissue prevention and repair products.
KEY MARKET PLAYERS:
Companies playing a significant role in the MEA soft tissue repair market profiled in the report are LifeCell Corporation, Organogenesis, C.R. Bard Inc., Johnson & Johnson, Covidien plc, Arthrex Inc., Smith & Nephew plc, Integra Lifesciences Corporation, Wright Medical Technology, and Stryker Corporation.
Countries such as Saudi Arabia, South Africa, and the United Arab Emirates are anticipated to hold a considerable share of the MEA market.
The growing focus on minimally invasive procedures, the development of new biologic treatments, and increasing use of robotics and other advanced technologies are some of the latest trends contributing to the growth of the MEA soft tissue repair market.
The MEA soft tissue repair market is estimated to grow at a CAGR of 6.01% from 2022 to 2027.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]